Pharmacological Evaluation of Pandanus fascicularis Lam. Root Extracts

 

Farhana Alam Ripa1*, Fahmida Haque Riya1, Fowzia Alam1, Nishat Zareen Khair1*,

Raushanara Akter1*, Yesmin Begum2, Shafiqul Islam1, Ashfaq Ahmed1

1School of Pharmacy, BRAC University, Kha-208, 1 Bir Uttam Rafiqul Islam Avenue, Dhaka-1212, Bangladesh.

2Department of Pharmacy, Southeast University, 251/A Tejgaon I/A, Dhaka 1208, Bangladesh.

*Corresponding Author E-mail: ripa.seu@gmail.com, zareen.nishat@bracu.ac.bd, raushanara@bracu.ac.bd

 

ABSTRACT:

The current study sought to determine the pharmacological characteristics of the crude methanolic extract (MPF) of Pandanus fascicularis Lam. root and its soluble ethyl acetate (EAPF) and chloroform (CPF) fractions through in vivo and in vitro approaches. This herb has been used for generations in Bangladesh to heal a variety of human diseases. Qualitative phytochemical tests confirmed the presence of alkaloid, glycoside, flavonoid, tannin, resin etc. CPF exhibited highest antioxidative potential through the DPPH (2, 2-Diphenyl -1- Picrylhydrazyl) radical quenching technique (IC50 39.89). In case of analgesic tests, CPF demonstrated uppermost inhibition in both formalin assay (55.82% in early phase and 58.18% in late phase) and acetic acid-induced writhing method (49.17%) at 400 mg/kg dose in mice. MPF showed a significant (p<0.01) diminution in locomotion of rodents in both open field and hole cross methods at utmost dose in comparison with the control group. In oral glucose tolerance test, all extracts significantly reduced blood glucose level following glucose loading (p<0.01, p<0.05) of animals in a dose dependent manner and CPF was found to have substantial hypoglycemic effect (6.4±0.14 mmoles/L at 400 mg/kg). All extracts considerably reduced the incidence of diarrheal episodes in mice in diarrheal tests (castor oil and magnesium sulphate induced diarrhea). EAPF and CPF showed remarkable thrombolytic (EAPF-25.41±1.48% and CPF-31.35±2.05% lysis) and antiarthritic (EAPF-80.33±0.86% and CPF-87.26±1.02% inhibition) effects in comparison to the reference drugs in the respective tests. All samples showed notable anthelmintic activity as proved by declined paralyzing and death time of Pheretima posthuma in anthelmintic assay. For insecticidal test with Tribolium castaneum, only CPF exhibited moderate mortality rate (50%) compared to others at 50mg/mL. These findings can be considered a benchmark for the future isolation of pure bioactive chemicals from this plant in the development of new phytomedicines.

 

KEYWORDS: Pandanus fascicularis Lam., antioxidant, analgesic, Pheretima posthuma, Tribolium castaneum.

 

 


INTRODUCTION: 

Since the dawn of time, people have exploited a variety of natural resources to treat illnesses rather than accepting their inevitable deaths1,2.

 

Due to the existence of several unique entities, the scientific literature on medicinal flora has recently noticed a boom focused on the utilization of them for their diverse health benefits and therapeutic potentials in the pharmaceutical and nutrition sciences. The World Health Organization (WHO) reported that the phytomedicines usage rate has expanded three times faster than that of conventional medicines, and approximately 80% of the developing-world populations rely on medicinal plants for basic healthcare since they are thought to exert fewer adverse effects. Nearly 33% of the medications manufactured today in affluent nations are derived from plants. Previous studies revealed that phytoconstituents (alkaloids, flavonoids, tannin, glycosides, etc.) have a wide range of pharmacological activities and might be used to treat a number of ailments such as cancer, diabetes, inflammatory disorders, cardiovascular complications, obesity etc.2-5.

 

Pandanus fascicularis Lam, also known as screw pine, is an evergreen tree or shrub with delicate blossoms that resembles a palm and is native to South Asia (Bangladesh, India, Japan etc.). It is primarily found in subtropical and tropical climates and is particularly common in mangrove swamps. The plant's parts have traditionally been employed to alleviate rheumatoid arthritis, leprosy, edema, tumors, earaches, fever, skin conditions, ulcers, and dyspepsia. Researchers reported the presence of tannins, carbohydrates, flavonoids, steroids, saponins, hematoporphyrin, decanoic acid, proteins, terpenes, phenols, glycosides, glucose, and alkaloids in different parts of P. fasciculari 6,7.

 

Despite the numerous traditional applications of this plant, a very few studies have been conducted on the ethnopharmacological applications and phytoconstituents of root of P. fascicularis. There is a large gap of knowledge about the pharmacological activity of this plant part which must be explored. This prompted us to investigate the in vivo (analgesic, CNS depressant, antidiarrheal, hypoglycemic) and in vitro (antiarthritic, thrombolytic, anthelmintic, and insecticidal) properties of methanolic root extract and its various solvent sections of the aforementioned plant. The finding from our study indicates that the pharmacological activities of root of P. fascicularis can be considered as a benchmark for the future isolation of pure bioactive chemicals for the development of new phytomedicines to treat free radical induced neurodegenerative diseases, diabetes, arthritis, etc.

 

MATERIALS AND METHODS:

Plant sample collection, authentication, and extraction:

The fresh root of the plant P. fascicularis was collected from the Sundarbans, Bangladesh in January, 2023 and was identified by a taxonomist from the Bangladesh National Herbarium in Mirpur, Dhaka (DACB Accession No: 88421). The crude methanolin extract (MFP) and its fractions(chloroform-CFP, and ethyl acetate- EFP ) were prepared according to previous method8. The extracts were then preserved properly to evaluate their in vivo and in vitro pharmacological characteristics.

 

Chemicals:

Diazepam, morphine, metformin, loperamide, streptokinase, and albendazole were generous gifts from Popular Pharmaceuticals Ltd. (a renowned pharmaceutical company in Bangladesh). Ascorbic acid, acetic acid, and methanol (95%) were purchased from Merck (Germany). Analytical grade materials were used for all other reagents in the investigations.

 

Test Organisms and Experimental Animals:

Here we used Swiss albino mice of both sexes (age 4-5 weeks, weight 25-30gm) for in vivo pharmacological studies (at 3 distinct doses: 100, 200, and 400mg/kg for the experimented extracts). They were purchased from the Animal Resources Division of the International Center for Diarrheal Disease Research, Bangladesh (ICDDR, B). Prior to pharmacological investigations, all rodents were kept in the standard laboratory condition for near about a week to acclimatize to the laboratory environment9. The animal ethical committee of the Southeast University (Dhaka, Bangladesh) authorized each animal experiment protocol (SEU/Pharm/CERC/110/2023). Oral gavage was used to provide each agent via the oral route. Indian earthworms (Pheretima posthuma) and Tribolium castaneum (red flour beetle) were collected from Sher-e-Bangla Agricultural University, Bangladesh.

 

Preliminary phytochemical screening:

Standard techniques were used to check the presence of distinct bioactive components in the tested extracts (MPF, EAPF and CPF)10,11.

 

In vivo Studies:

Analgesic activity:

Analgesic effect of the tested samples was studied through writhing (acetic acid induced)3,12 and formalin induced pain methods13. The following equation was used to compute the proportion of the treated group's writhing inhibition:

 

% Of inhibition of weithing – [(Ncontrol – NTest) / control] × 100%

Where, N represents the mean number of writhing for each group.

 

CNS Depressant activityL:

Plant extracts' CNS depressing action was examined using the open field and hole cross methods according to previous methods with minor modification14.

 

Hypoglycemic Test (Oral Glucose Tolerance Test-OGTT):

Healthy rodents were subjected to the oral glucose tolerance test (OGTT) according to the method of Tesfaye et al.15 and used the equation below to calculate the percent drop in blood sugar level caused by P. fascicularis extracts:

% Reduction in blood glucose = [BGLcontrol – BGLtest) / BGLcontrol] × 100%

Here, BGL is the mean blood glucose level for each group.

Antidiarrheal Activity:

The plant samples were also subjected to ensure the anti-diarrheal effect in mice by castor oil and magnesium sulphate induced diarrhea models12,16.The percentage of defecation inhibition was estimated as follows:

 

% Inhibition of defecation = [A – B) / A] × 100%

Where, A and B represent the mean number of feces induced by castor oil/magnesium sulphate, and drug/ extract respectively.

 

In vitro studies:

DPPH radical scavenging assay:

The antioxidant potential of the experimented plant extracts was measured with the previously described DPPH scavenging assay17-19 technique with little modification. The free radical quenching capacity was measured with the following formula:

 

%Of inhibition = [(Ablank – Asample) /Ablank] × 100%

Here, A means absorbance for each group. A graph showing the relationship between test material concentration and DPPH scavenging inhibition was then used to determine the IC50 value (50% inhibition) for each plant sample.

 

Thrombolytic property:

Using a previously reported approach8, we assessed the thrombolytic capability of P. fascicularis root extracts. The % clot lysis was determined by applying the equation beneath20:

 

%Clot lysis = [Weight of clot lysis / Weight of clot before lysis) × 100%]

 

Antiarthritic property:

The percentage inhibition of protein denaturation was calculated using the following formula by following previous described antiarthritic test21:

%Inhibition = [(Absorbance of control –

Absorbance of test samples /

Absorbance of control] ×100%

 

Anthelmintic test:

With some minor tweaks, previous approaches22,23 were used to study the anthelmintic activity of P. fascicularis extracts.

 

Insecticidal activity screening:

The insecticide capability of the investigated materials was evaluated against T. castaneum using the following formula24.

Er = (Eo – Ec / 100 – Ec) × 100%)

Er = Corrected percentage of mortality; Eo = Experiential percentage of mortality; Ec = Control percentage of mortality

 

Statistical analysis:

The findings were shown as mean ± SEM. One-way analysis of variance (ANOVA) was used to evaluate data between groups, followed by Dunnett's test where p value <0.05 regarded statistically significant (SPSS software, version 26.0, IBM Corporation, Armonk, NY, USA).

 

RESULTS:

Preliminary phytochemical screening:

Table 1 summarizes the findings of the phytochemical screening of P. fascicularis root extracts. The crude methanolic extract and its fractions showed the presence of numerous beneficial secondary metabolites.

Table 1: Phytochemical screening test of P. fascicularis root extracts

Phytocompounds

MPF

EAPF

CPF

Glycoside(Borntrager’s test)

++

+

++

Carbohydrate(Molisch’s Test & Benedict’s test)

++

++

++

Resin Ferric chloride test)

+

+

++

Alkaloid(Mayer's test & Dragendorff's test)

++

+

+++

Saponin(Frothing test)

+

+

+++

Tannin(Catechin test)

++

+

+++

Steroid(Liebermann Burchard test)

+

+

++

Flavonoid(Shinoda test)

++

+

+++

Phenol(Ferric chloride test)

+++

+

+++

Fixed oil(Stain test)

+

-

-

Terpenoids(Salkowski test)

+

-

++

Note: Here, “+” states the presence and “-” shows the absence of any phytochemical group. Bioavailability key: (+++) ve = robust intensity, (++) ve = medium intensity, (+)ve poor intensity,(−) ve = absent.

In vivo studies: Analgesic activity:

In writhing test, all extracts notably (p<0.01; p< 0.05) decreased the number of writhes in mice compared to the negative control (Table 2) at all doses. The MPF extract at the higher dose (400 mg/kg) exhibited maximum percent of writhing inhibition 49.17%. The median length of time that animals spent beating the injected paw in each of the two phases was considerably reduced by all tested extracts in formalin lick test (Table 3). We noticed that CPF extract at higher dose displayed improved pain prevention in both phases (early phase 55.82% and late phase 58.18%).

 

Table 2: Effect of root extracts of P. fascicularis on acetic acid-induced writhing in mice

Group

Treatment / Dose (mg/kg)

Number of Writhing

% of Inhibition

Control (I)

Tween 80 solution

30.83 ± 0.98

-------

Standard (II)

Morphine/ 2 

9.0 ± 0.63b

70.81

III

MPF/ 100

23.17± 1.18a

24.85

IV

MPF/ 200

17.83 ± 0.76a

42.167

V

MPF/ 400

15.67 ± 0.82b

49.17

VI

EAPF/ 100

26.17± 0.75a

26.17

VII

EAPF/ 200

20.67 ± 0.82a

32.95

VIII

EAPF/ 400

16.50 ± 1.05b

46.48

IX

CPF/ 100

26.83± 1.17a

12.97

X

CPF/ 200

21.33 ± 1.21a

30.81

XI

CPF/ 400

19.17 ± 0.75b

37.82

Note: The data are presented as mean ± STD (n=5); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 

CNS Depressant activity:

The outcomes of open field and hole cross tests are given in Table 4 and Table 5. All extracts significantly reduced the locomotor activity in mice (p<0.01; p< 0.05) in both methods. In comparison to MPF and EAPF extracts, the CPF of showed more notable effects. The findings demonstrated that practically all P fascicularis root extracts considerably (p<0.01; p<0.05) reduced the number of holes the mice crossed over time from their initial value.

 

Hypoglycemic Test:

From 30 minutes on, all extracts in the OGTT significantly reduced the plasma glucose levels (Table 6). CPF exhibited the strongest hypoglycemic activity among all extracts.


 

Table 3: Anti-nociceptive activity of P. fascicularis root extracts in formalin-induced lick test

Groups

Treatment

/Dose (mg/kg)

Early phase (Sec)

Late phase (Sec)

% Protection of early phase

% Protection of late phase

Control (I)

Tween 80

solution

37.17 ± 1.47

47.83 ± 0.75

 

 

Standard (II)

Morphine / 2 

15.17 ± 0.75b

17.0± 0.63b

59.19

64.46

III

MPF / 100

30.83 ± 1.47b

32.67 ± 1.63a

17.06

40.77

IV

MPF / 200

23.50± 1.05b

28.00 ± 1.26b

36.78

41.46

V

MPF / 400

19.33 ± 1.03

23.0 ± 0.89b

47.99

50.51

VI

EAPF / 100

32.5± 1.04b

27.17± 1.47

12.56

43.19

VII

EAPF / 200

26.0± 0.89b

30.67 ± 0.82a

30.05

35.88

VIII

EAPF / 400

21.83 ± 1.33

25.67 ± 0.82

41.27

46.33

IX

CPF / 100

33.66±0.81a

40.67± 1.21a

9.44

14.97

X

CPF / 200

30.5 ± 1.04b

35.0 ± 0.89b

17.94

26.82

XI

CPF / 400

20.33 ± 0.82b

20.00± 1.26b

55.82

58.18

Note: The data are presented as mean ±STD (n=5); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 

Table 4: P. fascicularis root extracts' effects in the open field test

Groups

Treatment/Dose

(mg/kg)

Number of Movements

0 min

30 min

60 min

90 min

120 min

Control (I)

Tween 80 solution

128.4± 0.49

123.0± 0.63

121.2± 0.74

118.4± 0.48

116.6± 0.49

Standard (II)

Diazepam/1 

122.8 ±0.84a

65.2 ± 0.83b

46.2±1.30b

17.2± 0.83b

10.2 ± 0.85b

III

MPF/100

123.0 ± 1.22

96.8 ± 0.84a

86.0± 1.58a

76.0± 0.89b

67.0 ± 1.58a

IV

MPF/200

120.8± 0.83a

87.2 ± 1.48b

76.4 ±.14b

54.2 ±1.648a

55.0 ± 1.87b 

V

MPF/ 400

120.6± 0.89a

77.8± 0.83

70.2 ± 1.30

62.2 ±1.79b

48.0 ± 0.71a

VI

EAPF/100

125.0 ±0.71a

112.4 ± 0.55b

99.2± 1.30a

88.8± 1.64a

77.8 ± 0.85a

VII

EAPF/ 200

124.6 ± 0.55

97.6 ± 1.67

80.2± 1.30a

67.2± 1.64a

57.6 ± 0.54a

VIII

EAPF/ 400

121.2 ±1.30a

80.4 ± 1.52

73.2± 0.84a

65.0± 1.22b

46.2 ± 1.09b

IX

CPF/ 100

126.2 ±0.84a

119.0 ± 0.71b

97.8± 0.84a

87.6± 0.55a

74.6 ± 1.14a

X

CPF/ 200

125.2 ±0.45a

110.6 ± 1.52a

89.6±1.14b

76.2± 1.30b

66.2 ± 1.48b

XI

CPF/ 400

123.2 ±0.54a

78.4 ± 0.89b

69.2±0.83b

59.6± 1.14b

54.6 ± 1.52b   

Note: The data are presented as mean ± STD (n=5); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 

Hole cross method

Table 5: P. fascicularis root extracts' effects in the hole cross test

Groups

Treatment/Dose

(mg/kg)

Number of movements

0 min

30 min

60 min

90 min

120 min

Control (I)

Tween 80 solution

21.0±0.63

18.4±0.8

15.2±0.75

14.4±0.74

13.8±0.49

Standard (II)

Diazepam/1 

14.8±0.75a

8.0±1.40a

4.8±0.75b

3.2±0.40b

1.6±0.80b

III

MPF/100

15.4±0.49a

13.2±0.75a

11±0.89a

7±0.75

6.6±0.80a

IV

MPF/200

14.41±1.02a

12±0.89a

8.0±0.89a

6.4±0.49

4.4±0.80b

V

MPF/ 400

12.0±1.02a

9.4±0.48a

7.4±0.49a

5.6±0.80b

4.0±0.63a

VI

EAPF/100

19.0±0.49

16.0±0.89a

14.0±0.63a

12.8±0.40a

11.6±0.80b

VII

EAPF/ 200

17.4±0.89a

14.0±0.63a

11.8±0.40a

11.2±0.98b

9.6±0.49a

VIII

EAPF/ 400

16.8±0.75a

14.4±0.48b

11.0±0.89a

9.2±0.97b

7.4±0.80b

IX

CPF/ 100

20.0±0.63a

16.4±0.80a

15.8±0.40

14.0±0.89a

12.6±0.49a

X

CPF/ 200

20.0±0.52a

14.6±0.98b

10.4±0.48a

8.4±0.49

7.8±0.75a

XI

CPF/ 400

18.0±0.63a

14.0±0.89a

10.8±0.98b

8.6±0.48b

6.2±0.75b

Note: The data are presented as mean ± STD (n=5); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 

Table 6: Effect of P. fascicularis root extracts' on OGTT in healthy rodents

Groups

Treatment/Dose

(mg/kg)

Blood Glucose level

0 min

30 min

1 hour

2 hours

3 hours

Control (I)

Tween 80 solution

9.53±0.49

23.78±0.48

18.5± 0.71

15.33±0.62

10.25±0.52

Standard (II)

Metformin/10

8.38 ±0.33b

16.53±.67b

10.78±0.79b

6.22±0.59b

4.12 ± 0.62b

III

MPF/100

9.18 ± 0.58

20.67±0.69a

19.28± 0.38a

16.55± 0.25a

10.28 ± 0.29a

IV

MPF/200

9.22± 0.41

18.58±.67b

15.27 ±0.29b

13.95±0.16b

10.37 0.44b

V

MPF/ 400

8.30± 0.36

17.27± 0.53

13.10± 0.35

10.2 ± 0.38a

7.05 ± 0.38a

VI

EAPF/100

8.45± 0.37

21.67±0.84b

19.28± 0.38a

16.55± 0.25a

13.17 ± 0.29a

VII

EAPF/ 200

9.21± 0.41

18.58 ± 0.67

15.27± 0.28b

13.95±0.16b

10.36 ± 0.44a

VIII

EAPF/ 400

8.30 ± 0.35

17.26 ± 0.53

13.1± 0.35

10.2± 0.38b

7.05 ± 0.38a

IX

CPF/ 100

8.55 ± 0.31a

21.33±0.40a

19.63± 0.21a

17.23± 0.34a

13.18 ± 0.31a

X

CPF/ 200

9.25 ± 0.36

19.12±0.57a

15.63± 0.19b

13.8± 0.25b

9.62± 0.23a

XI

CPF/ 400

8.67 ± 0.61b

17.6 ± 0.48b

12.52± 0.19b

9.57± 0.28b

6.4± 0.14b

Note: The data are presented as mean ± STD (n=6); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 


Diarrheal Tests:

All tested extracts significantly (p< 0.05 and p< 0.01, versus negative control) and dose-dependently reduced the overall number of diarrheal stools in both diarrhea tests (Table 7 and Table 8). CPF displayed the strongest inhibitory action, which varied with dose, among all the extracts.

 

Table 7: Effect of P. fascicularis root extracts at various dose levels on castor oil-induced diarrhea in mice

Groups

Treatment / Dose (mg/kg)

Total no. of Feces in 4 hours

% of inhibition

Control (I)

Tween 80 solution

21.67±1.03

 

Standard (II)

Loperamide/ 2 

4.83±1.16b

77.71

III

MPF/100

17.17±0.75a

20.77

IV

MPF/200

13.16±1.33a

39.27

V

MPF/ 400

9.33±0.82a

56.94

VI

EAPF/100

18.16±0.98a

16.19

VII

EAPF/ 200

13.83±0.75a

36.18

VIII

EAPF/ 400

11.50±1.04b

46.91

IX

CPF/ 100

16.50±0.55a

23.86

X

CPF/ 200

11.67±0.81a

46.15

XI

CPF/ 400

8.67±0.81b

59.99

Note: The data are presented as mean ± STD (n=6); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the control.

 

Table 8: Effect of P. fascicularis root extracts at various dose levels on magnesium sulphate-induced diarrhea in mice

Groups

Treatment / Dose(mg/kg)

Total no. of feces in 4 hours

% of inhibition

Control (I)

Tween 80 solution

19.33±1.21

 

Standard (II)

Loperamide/ 2 

4.17±0.75b

78.43

III

MPF/100

15.67±1.03a

18.93

IV

MPF/200

13.5±0.54a

30.16

V

MPF/ 400

10.00±0.89b

48.27

VI

EAPF/100

15.33±0.52a

20.69

VII

EAPF/ 200

13.83±0.75b

28.45

VIII

EAPF/ 400

11.67±1.03a

39.63

IX

CPF/ 100

17.33±0.55a

10.35

X

CPF/ 200

10.33±1.21a

46.56

XI

CPF/ 400

8.17±0.41b

57.73

Note: The data are presented as mean±STD (n=6); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b= p<0.01 significant compared to the control.

In vitro studies:

DPPH radical scavenging assay:

The studied materials revealed concentration-dependent quenching properties against the DPPH radical in the antioxidant experiment (Figure 1). The CPF was noticed to be more potent DPPH scavenger with an IC50 value of 39.89 in comparison to the standard ascorbic acid (IC50 35.67).

 

 

Figure 1: IC50 values of the experimented extracts and Standard.

 

Thrombolytic test:

The investigated extracts exhibited noteworthy thrombolytic efficacy (Figure 2). CPF exhibited the greatest degree of clot lysis among the studied samples (31.35±2.05%).

 

 

Figure 2: Thrombolytic activity of P. fascicularis root extracts. Results are reported as the mean standard deviation of triplicate measurements (mean ± SEM; n=3); and analyzed by One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test. *p<0.05, **p<0.01 significant compared to the control.

 


Table 9: In-vitro anti-arthritic activity of P. fascicularis root extracts in different concentrations

Sample

% of Inhibition at Concentration (μg/ml)

100

200

300

400

500

Diclofenac sodium

72.48±1.78

78.75± 0.55

84.46±0.89

90.12±3.08

92.77±0.96

MPF

60.48±1.89a

62.34±1.36b

68.34±0.91a

72.26±0.94b

74.29±1.05a

EAPF

63.23±1.89

66.41±1.41b

71.66±0.59b

77.19±2.25a

80.33±0.86b

CPF

66.55±0.95b

70.44±1.14b

75.31±1.12b

83.26±1.02b

87.26±1.02b

Note: The data are presented as mean±STD (n=3); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test; a=p<0.05, b=p<0.01 significant compared to the standard.

 


Antiarthritic Activity:

Table 9 presents the comprehensive findings of the atiarthritic test. CPF showed the highest percentage of inhibition (87.26±1.02% at 500µg/ml), while MPF showed the lowest percentage of inhibition (60.48±1.89% at 100µg/ml).

 

Anthelmintic Test:

Table 10 lists the results of the anthelmintic activity of roof extracts of P. in comparison to albendazole .

 

Table 10: Anthelmintic activity of P. fascicularis root extracts at different concentrations

Groups

Conc. Used (mg/ml)

Time taken for paralysis (min) X±SD

Time taken for death (min) X±SD

Control (I)

-----

-----

-----

Albendazole (II)

20

33.67±1.53

42.00±2.00

MPF (III)

25

77.00±1.00a

82.00±4.36a

50

64.33±1.53a

69.66±2.52a

75

59.00±1.00b

64.66±4.16

EAPF (IV)

25

68.67±0.50a

68.33±3.21a

50

53.67±2.08b

61.67±2.51a

75

50.33±1.53b

56.33±1.52b

CPF (V)

25

56.00±1.00a

64.66±4.16a

50

49.05±0.58a

53.66±2.08b

75

39.66±2.08b

44.33±1.52b

Note: The data are presented as mean ± STD (n=6); One-Way Analysis of Variance (ANOVA) trailed by Dunnet's test.; a=p<0.05, b=p<0.01 significant compared to the control.

 

Insecticidal test

Figure 3 shows the impact of contact poisoning of root extracts of P. fascicularis on adult T. castaneum mortality.

 

 

Figure 3: Insecticidal effects of root extracts of P. fascicularis

DISCUSSION:

Plant bioactive constituent assure the medicinal potential and their therapeutic actions 1-4,25,26. To isolate new active and scarce compounds, phytochemical investigation is crucial. In recent study we extracted the root of P. fascicularis with methanol and fractionated in ethyl acetate and chloroform solvents. The experimented extracts exhibited the presence of various secondary metabolites (Table1 ). The previous literature also supported the presence of 2-phenyl ethyl methyl ether, terpene-4-ol, α–terpeniol, benzyl benzoate, flavanoids, glycosides, alkaloids, steroids, terpenoids, saponins and tannins in different parts of P. fascicularis,. Traditionally the examined plant parts are used to alleviate rheumatoid arthritis, leprosy, edema, tumors, earaches, fever, skin conditions, ulcers, and dyspepsia6,7.

 

Writhing test (acetic acid-induced) and Licking (formalin-induced pain) test were used to assess the analgesic effectiveness of P. fascicularis root extracts. After receiving acetic acid intraperitoneally, the body releases histamine, prostaglandins (PGs), serotonin, Cyclooxygenase (COX), bradykinin, and cytokines which cause pain by contraction of the abdominal muscles3,4. Our extracts decreased writhing in the current investigation (p<0.01, p<0.05; Table 2). We conducted the Licking test on the plant extracts under study to distinguish between their central and peripheral antinociceptive activities. In our investigation we noticed that all tested samples significantly (p<0.01, p<0.05) reduced the mean time of beating the formalin injected paw in both phases (Table 3). The CPF was found to be most potent in all phases (early phase 55.82% protection and in late phase 58.18% protection). Therefore, based on the outcomes of our study, all extracts also have peripheral and central antinociceptive effects in along with additional anti-inflammatory activity. Bioactive phytoconstituents such as flavonoids, alkaloids, and terpenoids, which have been linked to considerable analgesic and anti-inflammatory effects in previous pharmacological studies3,4,10,19, were also found in our tested extracts.

 

The CNS depressive impact of P. fascicularis root extracts was investigated utilizing two neuropharmacological approaches, namely open field, and hole cross, by examining the naturalistic locomotor behavior of mice. These paradigms are well-known traditional methods for examining neuropharmacological action10,19. Here, CPF extract produced highly significant effects than other extracts at higher dose (400 mg/kg) (Table 4 and Table 5). A decrease in locomotor activity is a sign of CNS depressing activity and is seen as an indication of awareness19,27. When the voltage-triggered Ca2+ channel is hindered, it can either enhance chloride conductivity or increase GABA-induced chloride conduction. As a result, the extracts are likely to either directly activate GABA receptors or amplify GABAergic suppression in the CNS via membrane hyperpolarization, resulting in a decrease in the firing rate of crucial brain neurons1,3,4. The secondary metabolites (flavonoids, terpenoids, saponin, etc.) of the plant that may have synergistic effects at one or more target sites connected to a physiological function are responsible for the extracts' depressant activity3,4.

 

A medicine that effectively treats diabetes will be able to regulate the rise in blood sugar using a variety of mechanisms, and the potential of extracts to avoid hyperglycemia might be assessed with OGTT15. Because it temporarily boosts the animal's blood glucose level without causing injury to the pancreas, this approach is known as the physiological induction of diabetes mellitus12,15. In comparison to the reference metformin, the crude methanolic root extract (MPF) and it fractions (EAPF and CPF) demonstrated a remarkable hypoglycemic activity (p<0.05, p<0.01; Table 6) in rodents during the glucose tolerance test that persisted for up to 3 hours which might be due to the presence of, various significant bioactive phytoconstituents like falvonoids, tannin etc.25,26.

 

The antidiarrheal effectiveness of the investigated plant extracts was assessed using models of diarrhea induced by castor oil and magnesium sulphate. Castor oil consumption increases the intestinal absorption of ricinoleic acid released by intestinal lumen lipase. By influencing gut motility and ultimately causing diarrhoea, ricinoleic acid exerts a significant laxative effect on mice through the prostaglandin receptor EP212. All experimental extracts significantly (p < 0.05, p<0.01) decreased diarrhea by dropping the volume of intraluminal fluid accumulation in a dose-dependent manner in the castor oil-induced diarrheal test (Table 7). Magnesium sulphate, on the other hand, also causes diarrhea by preventing salt chloride and water reabsorption and increasing the volume of intestinal content. Cholecystokinin is released from the duodenal mucosa when this salt is consumed, which causes diarrhea16. Significant anti-diarrheal efficacy was shown by P. fascicularis root extracts (MPF, EAPF, and CPF) against magnesium sulphate-induced diarrhea (Table 8). At all trial doses compared to the standard, extracts significantly (p<0.05, p<0.01; Table 7 and Table 8) enhanced the percentage of inhibition and also noticeably decreased the number of diarrheal feces. The presence of flavonoids and tannin may be the cause of the extracts capacity to reduce intestinal output12,16.

 

Antioxidants with the ability to quench free radicals are crucial in the treatment of different pathological state. Because of this, there is a growing interest in creating natural antioxidants derived from plants that are capable of safeguarding the body from damage caused by oxidative stress brought on by free radicals. The most used technique for assessing the antioxidant capacity of plant materials is the DPPH scavenging assay. The tested plant exhibited moderate antioxidant potential against DPPH free radicals, as shown in Figure 1. Numerous bioactive phytochemical components, particularly phenolic compounds, are crucial for both the antioxidant and free radical scavenging effects of plants which were also found in our extracts.

 

Recent studies by epidemiologists employing plant and natural products have demonstrated that natural thrombolytic/fibrinolytic medications lower the risk of thrombosis in contrast to synthetic products12,20,21. In our investigation, crude root extract of P. fascicularis and its fractions revealed notable thrombolytic activity in comparison to reference standard streptokinase. Among the extracts examined, CPF exhibited the highest percentage of clot lysis (31.35±2.05%) followed by EAPF (25.41±1.48%) and MPF (20.83±1.19%) (Figure 2). Numerous investigations have demonstrated that saponins, alkaloids, and tannins are triggering clot lysis activity8,20,21 which were also confirmed in our extracts.

 

Tissue protein denaturation, a primary contributor to arthritic diseases, can create autoantigens in numerous situations. Protein denaturation can be caused by several physical and chemical factors, including heat, light, pressure, acids, alcohol, alkali, acetone, heavy metal salts, and dyes, as well as alterations in the disulfide, hydrogen, hydrophobic, and electrostatic interactions in the protein8,21. All the extracts in this investigation show dose-dependent denaturation of bovine serum albumin. The chloroform fraction of the study (Table 9) was found to be most active at 500μg/ml dose (87.26±1.02%). This study revealed the presence of flavonoids and phenolic substances in plant extracts, which were claimed to have anti-arthritic properties in previous studies8,21.

 

Natural resources like plants can also yield novel physiologically active compounds that are compatible with human physiology and have no negative effects or less than those of synthetic anthelmintic compounds8,21-23. In the anthelmintic study, we distinguish between plant extracts and regular albendazole in terms of the length of earthworm paralysis and death. In this case, we discovered a statistically significant association between extract graded concentrations, exposure periods, and adult parasite mortality. The chloroform fraction demonstrated (Table 10) possible reductions in paralysis (39.66±2.08min) and death (42.0±2.0min) times compared to standard (33.67±1.53min and 44.33±1.52 min, respectively) among all examined extracts at higher dose (75mg/ml). Copious investigations suggested that tannins, flavonoids, alkaloids, and phenolic chemicals are responsible for the anthelmintic activity8,21-23 which were also confirmed by our study.

 

Herbal products have recently gained popularity due to their significant potential as insecticidal chemicals2,24. In our present research we observed that the examined extracts exhibited little insecticidal activity against adult T. castaneum. Previous research reported the presence of bioactive components in plant extracts such as polysaccharides, phenol, flavonoids, phytosterol, saponins and tannins can have repellant, antifeedant, and poisonous properties27-30.

 

CONCLUSION:

The root of P. fascicularis was found to contain a large number of secondary bioactive metabolites, such as glycosides, alkaloids, tannin, saponin, flavonoids, terpenoids, and so forth. These metabolites had a variety of effects, including analgesic, CNS depressant, hypoglycemic, antidiarrheal, thrombolytic, antiarthritic, anthelmintic, and insecticidal qualities. At every experimental dosage examined, the impact is immediate, persistent, and statistically significant. Our research leads us to the conclusion that P. fascicularis root may provide pharmaceutical companies with new, safe, effective, and less toxic candidate treatments, hence lowering the cost of treating diseases. However, more investigation is required to identify the bioactive molecule or compounds and comprehend the exact molecular pathways in order to determine a safe and effective dosage and validate the potential for use in treatment and prevention.

 

CONFLICT OF INTEREST:

The authors state unequivocally that they have no competing interests.

 

FUNDING INFORMATION:

For this study, the authors received no specific grant or financial assistance from any public, commercial, or non-profit funding bodies.

 

DATA AVAILABILITY STATEMENT:

The corresponding authors can provide the datasets created and/or examined during this study upon reasonable request.

 

REFERENCES:

1.      Abruzzo PM, Panisi C, Marini M. The Alteration of Chloride Homeostasis/GABAergic Signaling in Brain Disorders: Could Oxidative Stress Play a Role? Antioxidants (Basel). 2021; Aug 21; 10(8): 1316. doi: 10.3390/antiox10081316.

2.      Ahmad F, Iqbal N, Zaka SM, Qureshi MK, Saeed Q, Khan KA, et al. Comparative insecticidal activity of different plant materials from six common plant species against Tribolium castaneum (Herbst)(Coleoptera: Tenebrionidae). Saudi J. Biol. Sci. 2019; Nov; 26(7): 1804-8. doi:10.1016/ j.sjbs.2018.02.018.

3.      Paul S, Saha D. Analgesic Activity of Methanol Extract of Plumbago indica (L.) by Acetic Acid Induced Writhing Method. Asian J. Pharm. Tech. 2012; Apr-Jun; 2(2): 74-6.

4.      Dighe NS, Pattan SR, Nirmal SA, Kalkotwar RS, Gaware VM, Hole MB. Analgesic activity of Tamarindus indica. Res. J. Pharmacogn. Phytochem. 2009; 1(1): 69-71 .

5.      Shahid, Afia, Rehman KU, Rao H, Aati HY, Sherif AE, Khan DA, Abdul Basit, et al. 2022. Phytochemical Profiling of the Ethanolic Extract of Zaleya pentandra L. Jaffery and Its Biological Activities by In-Vitro Assays and In-Silico Molecular Docking. 2022; Appl. Sci.13; (1): 584. https://doi.org/10.3390/ app 130 10584.

6.      Shim SY. Pandanus fascicularis Lam Extract Inhibits Pro-Inflammatory Cytokines Production in LPS-Stimulated RAW 264.7 Cells. Prev Nutr Food Sci. 2019; Sep; 24(3): 344-347. doi: 10.3746/pnf.2019.24.3.344. Epub 2019 Sep 30.

7.      Jacob MJ, Balasundaram J, Venkatachalam G. Preliminary Phytochemical Screening and GC-MS Analysis of Methanolic Extract of Roots of Pandanus Fascicularis. Asian J. Biol. Sci. 2022 Jan, 626–31. https://doi.org/10.5530/ajbls.2021.10.83.

8.      Ripa FA, Hossain MJ, Nesa ML, Zahan MS, Mitra S, Rashid MA, Roy A, Alghamdi S, Almehmadi M, Abdulaziz O. Phytochemical and Pharmacological Profiling of Heritiera fomes Buch. Ham. Deciphered Thrombolytic, Antiarthritic, Anthelmintic, and Insecticidal Potentialities via In Vitro Approach. Evid Based Complement Alternat Med. 2022; Jul 18; 2022: 2594127. doi: 10.1155/2022/2594127.

9.      Shahed-Al-Mahmud M, Shawon MJA, Islam T, Rahman MM, Rahman MR. In Vivo Anti-diarrheal Activity of Methanolic Extract of Streblus asper Leaves Stimulating the Na+/K+-ATPase in Swiss Albino Rats. Indian J Clin Biochem. 2020 Jan;35(1):72-79. doi: 10.1007/s12291-018-0781-7. Epub 2018 Jul 21.

10.   Chy MNU, Chakrabarty N, Roy A, Paul A, Emu KA, Dutta T, Dutta E, Ferdous I, Das R, Hasan MJ, Tasnim SM. Antibacterial, anthelmintic, and analgesic activities of Piper sylvaticum (Roxb.) leaves and in silico molecular docking and PASS prediction studies of its isolated compounds. J Complement Integr Med. 2019; Aug 22; 16(4):/j/jcim.2019.16.issue-4/jcim-2018-0176/jcim-2018-0176.xml. doi: 10.1515/jcim-2018-0176.

11.   Souza AO, Bessa DHRF, Fernandes CC, Pereira PS, Martins CHG, Miranda MLD. Phytochemical screening of extracts from Spiranthera odoratissima A. St.-Hil.(Rutaceae) leaves and their in vitro antioxidant and anti-Listeria monocytogenes activities. Acta Sci. Biol. Sci. 2020; 42: 1-10. Doi:10.4025/actascibiolsci.v42i1.51881.

12.   Haque MR, Islam M, Kuddus MR. In vitro and in vivo evaluation of pharmacological potential of Begonia barbata Wall. Future J. Pharm. Sci. 2020; Dec; 6(1): 112. doi:10.1186/s43094-020-00129-8.

13.   Khan K, Rasool S, Khan K, Badshah SL, Ahmad N, Jan MT, et al. Computational evaluation and anti-inflammatory and analgesic activities of Nebrodenside A isolated from Dodonaea viscosa. Nat. Prod. Commun. 2019; May; 14(5): 1934578X19848157. doi:10.1177/1934578X19848157.

14.   Shahed-Al-Mahmud M, Lina SMM. Evaluation of sedative and anxiolytic activities of methanol extract of leaves of Persicaria hydropiper in mice. Clin. Phytoscience. 2017; 3: 1-12. doi:10.1186/s40816-017-0056-5.

15.   Tesfaye T, Teka F, Duga G, Obsa T, Dereje B, Makonnen E. Anti-Hyperglycemic and Hypoglycemic Activities of 80% Methanol Extract and Solvent Fractions of Ocimum lamiifolium Hochst Ex Benth. (Lamiaceae) Leaves in Mice. J Exp Pharmacol. 2023; Jun 6; 15: 255-266. doi: 10.2147/JEP.S409997.

16.   Shahed-Al-Mahmud M, Shawon MJA, Islam T, Rahman M, Rahman MR. In Vivo Anti-Diarrheal Activity of Methanolic Extract of Streblus asper Leaves Stimulating the Na+/K+-ATPase in Swiss Albino Rats. 2018, Indian J. Clin. Biochem. 35 (1): 72–79. https://doi.org/10.1007/s12291-018-0781-7.

17.   Gunasekaran B, Muralidharan P, Pandiselvi A, Amutha P. Preliminary Phytochemical screening and Antioxidant activities of Ethanolic extract of Caesalpinia sappan Linn. Res J Pharm Technol. 2008; July-Sept; 1(3): 179-181.

18.   Rangasamy P, Hansiya VS, Maheswari PU, Suman T, GeethaN. Phytochemical Analysis and Evaluation of In vitro Antioxidant and Anti-urolithiatic Potential of various fractions of Clitoria ternatea L. Blue Flowered Leaves. Asian J. Pharm. Ana. 2019; 9(2): 67-76. doi: 10.5958/2231-5675.2019.00014.0.

19.   Tiwari DK, Upmanyu N. Phytochemical and Pharmacological activity of Wonder Shrub: Calotropis gigantia. Res. J. Pharmacognosy and Phytochem.

20.   Guguloth SK, Malothu N, Kulandaivelu U, Koteswar Rao GSN, Areti AR, Noothi S. Phytochemical investigation and In vitro Thrombolytic activity of Terminalia pallida Brandis leaves Res. J. Pharm. Tech. 2021; 14(2): 879-882. doi: 10.5958/0974-360X.2021.00156.6.

21.   Ripa FA, Hossain MJ, Munira MS, Roy A, Riya FH, Alam F, et al. Phytochemical and pharmacological profiling of Trewia nudiflora Linn. leaf extract deciphers therapeutic potentials against thrombosis, arthritis, helminths, and insects. Open Chem. 20(1): 1304-12. doi: 10.1515/chem-2022-0244.

22.   Shamim QM, Giri IC, Panday VK, Choudhary R , Patel J. Anthelmintic activity of Smilex zeylanica leaf. . Res. J. Pharmacogn. Phytochem. 2009; 1(1):78-9.

23.   Chordiya SV, Pimprikar RB, Yeshwante SB, Tanvir Shaikh, Patil PN, Kale MK, Firke BM. Anthelmintic Activity of Hiptage benghalensis (L) Kurz Leaves . Res. J. Pharmacogn. Phytochem. 2009; 1(3): 234-35.

24.   Najem M, Bammou M, Bachiri L, Bouiamrine EH, Ibijbijen J, Nassiri L, et al. Essential Oil Has a Biological Potential for a Natural Fight against the Pest of Stored Foodstuffs: Tribolium castaneum Herbst. Evid.-based Complement. Altern. Med. 2020Aug 27; 2020: 5739786. doi:10.1155/2020/5739786.

25.   Chigozie IJ, Chidinma IC. Hypoglycemic, hypocholesterolemic, anti-anemic and ocular-protective effects of an aqueous extract of the rhizomes of Sansevieria liberica Gérôme and Labroy (Agavaceae) on alloxan induced diabetic Wistar rats. Asian J. Pharm. Tech. Oct. - Dec. 2011; 1(4): 137-48.

26.   Kumbhare M, Sivakumar T, Surana A. Evaluation of Hypoglycemic potential of Moringa oleifera bark extracts on normal and Alloxanized diabetic rats. Res J Pharm Technol. 2021; 13(2): 95-9. doi: 10.52711/0975-4377.2021.00017.

27.   Shoibe M, Chy MNU, Alam M, Adnan M, Islam MZ, Nihar SW, Rahman N, Suez E. In Vitro and In Vivo Biological Activities of Cissus adnata (Roxb.). Biomedicines. 2017; Oct 30; 5(4): 63. doi: 10.3390/biomedicines5040063.

28.   Tanveer M, Ejaz S, Zaka SM, Batool M, Zahra TE, Saghir M, Saeed Q. Toxicology of diatomaceous earth, phyto oils and their admixed emulsions against adults of Tribolium castaneum (Herbst). Toxicol Rep. 2022; May 16; 9: 1172-1179. doi: 10.1016/j.toxrep.2022.05.011.

29.   Ali SMA, Ammad AM, Ahmad SK, Bilal IM, Abdullah A, Talal I, et al. Effectiveness of different plant extracts along with new chemistry insecticide against Tribolium castaneum. GSC biol. pharm. Sci. 2020; 13(1): 095-100. doi:10.30574/gscbps.2020.13.1.0301.

30.   Shelke PS, Jagtap PN, Tanpure PR. In-vitro anthelmintic activity of Boswellia serrata and Aloe barbadensis extracts on Pheretima posthuma: Indian earthworm. Int. J. Res. Med. Sci. 2020; May; 8: 1843-7. doi:10.18203/2320-6012.ijrms20201939.

 

 

 

 

 

Received on 27.12.2023      Revised on 29.06.2024

Accepted on 09.11.2024      Published on 28.01.2025

Available online from February 27, 2025

Research J. Pharmacy and Technology. 2025;18(2):647-655.

DOI: 10.52711/0974-360X.2025.00096

© RJPT All right reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.